The level of negative impact this news has on Novavax.
During the beginning of the pandemic, Novavax (NASDAQ: NVAX) stock rose significantly as investors were optimistic about the company developing a COVID-19 vaccine. However, as the biotech company started to lag behind its competitors in developing a vaccine…
The level of negative impact this news has on Novavax. Read More »